Human Norovirus Evolution in a Chronically Infected Host.

scientific article

Human Norovirus Evolution in a Chronically Infected Host. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/MSPHERE.00352-16
P932PMC publication ID5371696
P698PubMed publication ID28405629

P50authorChristian SchwerkQ87687634
Horst SchrotenQ106411127
Grant HansmanQ41021048
Martin ChanQ50109028
P2093author name stringStefan Jennewein
Stefan Weichert
Anna Koromyslova
Sylvie Y Doerflinger
Ruediger Adam
P2860cites workRapid evolution of pandemic noroviruses of the GII.4 lineageQ21089614
Structural basis for the recognition of blood group trisaccharides by norovirusQ24682901
Immunogenetic mechanisms driving norovirus GII.4 antigenic variationQ24810360
X-ray crystallographic structure of the Norwalk virus capsidQ27619935
Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of VulnerabilityQ27667594
Norovirus gastroenteritis in immunocompromised patientsQ27694610
Structural analysis of bovine norovirus protruding domainQ27702874
Mechanisms of GII.4 norovirus persistence in human populationsQ28472177
Genetic and antigenic diversity among noroviruses.Q52665582
Detection of human enteric viruses in Japanese clams.Q54518741
Measuring H type 1 and H type 2 antigens in human saliva by immunoassay using artificial antigens as standard substancesQ72180721
Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirusQ81450056
High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolutionQ81936425
Unifying the epidemiological and evolutionary dynamics of pathogensQ29619092
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunityQ30352529
The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012.Q30358747
What is the reservoir of emergent human norovirus strains?Q30372827
Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008.Q30394408
Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.Q30409563
Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopesQ30425145
Recombination within the pandemic norovirus GII.4 lineageQ30428830
Detection and quantification of rare mutations with massively parallel sequencingQ30472217
The state of norovirus vaccinesQ33678125
Within-host evolution results in antigenically distinct GII.4 norovirusesQ33744124
Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated miceQ33962224
Mechanisms of GII.4 norovirus evolutionQ34163802
Structural requirements for the assembly of Norwalk virus-like particlesQ34335587
Enteric bacteria promote human and mouse norovirus infection of B cellsQ34446799
Chronic shedders as reservoir for nosocomial transmission of norovirusQ34489409
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variantQ35682819
Fecal viral load and norovirus-associated gastroenteritis.Q35793225
Contribution of intra- and interhost dynamics to norovirus evolutionQ35826200
Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006.Q36098883
Norovirus infections in symptomatic and asymptomatic food handlers in Japan.Q36314612
Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014Q36392388
Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Chiang Mai, ThailandQ36597589
Norovirus vaccine against experimental human Norwalk Virus illnessQ37144052
Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010-2013.Q37375402
Structural Basis for Norovirus Inhibition by Human Milk OligosaccharidesQ38293732
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patternsQ38353300
Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.Q39604515
Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotypeQ40344592
Structural Constraints on Human Norovirus Binding to Histo-Blood Group AntigensQ40700480
Proposal for a unified norovirus nomenclature and genotypingQ41513884
Human noroviruses' fondness for histo-blood group antigensQ41646214
Norwalk virus: how infectious is it?Q45394448
Existence of multiple genotypes associated with acute gastroenteritis during 6-year survey of norovirus infection in Japan.Q52009194
P433issue2
P921main subjectnorovirusQ1142751
P577publication date2017-03-29
P1433published inmSphereQ27727104
P1476titleHuman Norovirus Evolution in a Chronically Infected Host
P478volume2

Reverse relations

cites work (P2860)
Q64060326Genetic Susceptibility to Human Norovirus Infection: An Update
Q47553324Human Milk Oligosaccharides as Promising Antivirals
Q90435102Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket
Q57793004Human norovirus epitope D plasticity allows escape from antibody immunity without loss of capacity for binding cellular ligands
Q90639369Intra-Host Evolution of Norovirus GII.4 in a Chronic Infected Patient With Hematopoietic Stem Cell Transplantation
Q47107994Molecular Evolution of the VP1 Gene in Human Norovirus GII.4 Variants in 1974-2015.
Q44611786Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
Q90406871Norovirus Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced JAK/STAT Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses
Q92571688Nucleic Acid Induced Interferon and Inflammasome Responses in Regulating Host Defense to Gastrointestinal Viruses
Q64063758Structural Basis of Nanobodies Targeting the Prototype Norovirus
Q88643509The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity